Recruiting Chronic Myeloid Leukemia Studies in Anchorage
About Chronic Myeloid Leukemia Clinical Trials in Anchorage
Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.
There are currently 2 chronic myeloid leukemia clinical trials recruiting participants in Anchorage, AK. These studies are seeking a combined 417 participants. Research is being sponsored by Ascentage Pharma Group Inc., National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Myeloid Leukemia Clinical Trials in Anchorage — FAQ
Are there chronic myeloid leukemia clinical trials in Anchorage?
Yes, there are 2 chronic myeloid leukemia clinical trials currently recruiting in Anchorage, AK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Anchorage?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Anchorage research site will contact you about next steps.
Are clinical trials in Anchorage free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Anchorage studies also compensate for your time and travel.
What chronic myeloid leukemia treatments are being tested?
The 2 active trials in Anchorage are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.
Data updated October 15, 2026 from ClinicalTrials.gov